PCN50 COST-EFFECTIVENESS OF DOCETAXEL PLUS CYCLOPHOSPHAMIDE VERSUS DOXORUBICIN PLUS CYCLOPHOSPHAMIDE IN THE ADJUVANT TREATMENT OF OPERABLE BREAST CANCER
S Jones, L Chen, M Tangirala, L Asmar, P Airia, MF ThompsonVolume:
12
Year:
2009
Language:
english
DOI:
10.1016/s1098-3015(10)73287-3
File:
PDF, 87 KB
english, 2009